On the popular Chinese social media platform Xiaohongshu, also known as RedNote, an account called “Georgia Notes” (@格鲁吉亚小纸条) offers tips and advice to Chinese nationals planning a trip to the Republic of Georgia. In one post...
Human Germline Modification: Medicine, Science, Ethics, and Law
On May 14th, 2015, Stanford's Center for Law and the Biosciences and Stanford's Phi Beta Kappa Chapter co-hosted a panel event on editing the human germline genome, entitled "Human Germline Modification: Medicine, Science, Ethics, and Law.”
The event brought together top scholars and experts to discuss the law, ethics, and science behind CRISPR-CAS9 generally, and its application to the human germline more specifically. The speaker line-up included Marcy Darnovsky, Executive Director of the Center for Genetics and Society; CLB's Hank Greely; Paul Knoepfler, Professor of Cell Biology and Human Anatomy, UC Davis School of Medicine; Christopher Thomas Scott, Director, Stanford Program on Stem Cells in Society, and; Lynn Westphal, Professor of Obstetrics and Gynecology, Stanford University Medical School.
What follows are Marcy Darnovsky's comments. To watch the full length video of this event, please go to the Stanford Law School YouTube channel or by clicking here.